explore -WSS

explore

author：comprehensive 2025-09-30 03:38:20 - browse：34891

Sen. Bernie Sanders, I-Vt., chairman of the Senate Health, Education, Labor, and Pensions Committee listens during a hearing on Capitol Hill in Washington – politics and policy coverage from STAT — Senate health committee Chair Bernie Sanders (I-Vt.) wants to reward new medicines with prize money. Jose Luis Magana/AP

WASHINGTON — Sen. Bernie Sanders (I-Vt.) will finally get a study of his proposal to do away with drug patents and other intellectual property protections in favor of rewarding inventions with prize money. Sanders has been pushing the prize approach since he was a House representative, many years ago.

The measure directing the National Academies of Sciences, Engineering and Medicine to study the idea was added to the Pandemic All-Hazards and Preparedness Act a day before Sander’s health committee passed the bill. Three Republicans voted against the overall bill, which renews several federal biodefense and pandemic-preparedness programs.

Though Democrats last year passed historic legislation to let Medicare negotiate drug prices and cap seniors’ annual out-of-pocket drug costs, Sanders is demanding more drug price controls. He is delaying President Biden’s pick for running the National Institutes of Health until the president releases a plan to control drug prices.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： What drug price negotiations mean for Medicare Part D

WSS

Ethical issues complicate the benefits of medical crowdfunding

Illumina names Agilent executive as new CEO

Covid hospitalizations on the rise, Humana says

As health system earnings go up, health insurance stocks go down

Lawmakers grill UnitedHealth CEO on Change cyberattack

Sepsis can kill a child within hours. Here's how hospitals are fighting back

knowledge

explore

hotspot

At least 13 dead in Texas as scorching temps continue

Covid hospitalizations on the rise, Humana says

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Trump surgeon general acknowledges mistakes during Covid

How one medical school became remarkably diverse

What drug price negotiations mean for Medicare Part D

DIEP, the 'gold standard' of breast reconstruction, is under threat

Warren pushes Witty on UnitedHealth's control over physicians

Bright Health sells Medicare Advantage business to Molina

'Make People Better': The CRISPR babies story you probably don't know

entertainment

Sepsis can kill a child within hours. Here's how hospitals are fighting back

A rare thyroid diagnosis led to unexpected, all

House transparency, PBM reform bill gains bipartisan support

The creative science of coining drug names

The creative science of coining drug names

A rare thyroid diagnosis led to unexpected, all

hotspot

focus

hotspot

leisure time